Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.
Also called NCT01398384
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 250 participants
- Registry
-
NCT01398384
-
- Other papers using this trial's data
- Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Hungary, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01398384. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size
- Acronym
- NOMI
- Condition
- Acute Myocardial Infarction
- Intervention (Drug)
- Nitric Oxide
- Intervention (Drug)
- MI size at 48-72 hours
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
Record details
- Record id
cardio:ct-nct01398384- Content hash
aa957c470520640ef7e8a450c4b37b318f1fce850c2e05b4c29e16ce0a2bf093